4//SEC Filing
Reich Siegfried 4
Accession 0001209191-20-014800
CIK 0001595893other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:11 PM ET
Size
5.6 KB
Accession
0001209191-20-014800
Insider Transaction Report
Form 4
Reich Siegfried
EVP & Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2020-03-02+150,000→ 150,000 totalExercise: $51.28Exp: 2030-03-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on March 2, 2021 and 1/48th of the shares vest monthly thereafter over the next three years.
Documents
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001351888
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:11 PM ET
- Size
- 5.6 KB